Diaceutics Share News (DXRX)
DXRX Share
DXRX Share
DXRX Share
DXRX Share
DXRX
DXRX Share
DXRX Level 2
DXRX Live
DXRX Broker
DXRX Directors
DXRX Financial
DXRX
DXRX Short
DXRX
Last checked at -
(Sharecast News) - Diaceutics has secured a data licensing agreement with an unnamed global pharmaceutical company to provide Covid-19 testing data insights in the US, it announced on Thursday, enabled by its proprietary diagnostic network 'DXRX'.
Read more
IN BRIEF: Diaceutics inks deal to move to new head office
Read moreTRADING UPDATES: Ocean Wilsons annual profit slips; dividend unchanged
Read more(Sharecast News) - Diaceutics updated the market on its trading in 2020 on Monday, reporting that its revenue and adjusted EBITDA for the year ended 31 December were expected to be around £12.6m, down from £13.4m, and £0.5m, down from £2.2m respectively, with EBITDA breakeven.
Read moreIN BRIEF: Diaceutics Says 2020 Earnings To Beat Market Forecasts
Read moreIN BRIEF: Diaceutics Taps Former PayPal And eBay Exec As New Chair
Read moreUK TRADING UPDATE SUMMARY: Shoe Zone Ends Financial Year On Back Foot
Read more(Sharecast News) - Diaceutics announced the launch of its 'DXRX - The Diagnostic Network digital platform on Wednesday, which it said was designed to accelerate the development and commercialisation of precision medicine diagnostics using a new operating model.
Read moreDiaceutics Shakes Off Virus In First Half But Cautions On Full-Year
Read moreIN BRIEF: Diaceutics Wins Big Contract For US With Pharmaceutical Firm
Read more(Sharecast News) - Diagnostic commercialisation company Diaceutics announced a new, "significant" client contract win with an unnamed pharmaceutical company on Wednesday.
Read more(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Wednesday that it had built on its good start to the financial year, with trading in the first half in line with expectations.
Read moreUPDATE: Diaceutics Raises Almost GBP21 Million Ahead Of DXRX Launch
Read moreDiaceutics Raises Almost GBP21 Million Ahead Of DXRX Platform Launch
Read more(Sharecast News) - Diagnostics commercialisation company Diaceutics has conditionally raised £20.5m before expenses, through a placing of 14,137,931 new shares at 145p each to existing and new investors in two tranches, it announced on Thursday.
Read more
Last checked at